MENJUGATE lyophilisate + solvent for injection suspension medication leaflet

J07AH07 • meningococcal vaccine • Antiinfectives for systemic use | Bacterial vaccines | Meningococcal vaccines

The meningococcal vaccine is used to prevent infections caused by the Neisseria meningitidis bacteria, which can lead to bacterial meningitis and other severe infections, such as sepsis. These conditions can progress rapidly and be life-threatening, especially in children, adolescents, and individuals with weakened immune systems.

The vaccine provides protection against several meningococcal serogroups, most commonly A, C, W, Y, and B. There are different types of meningococcal vaccines, including conjugate and recombinant vaccines, which are recommended based on age, health status, and risk of exposure.

It is usually administered in one or more doses, depending on the type of vaccine and vaccination schedule. The vaccine is well-tolerated, with side effects generally being mild, such as redness or pain at the injection site, mild fever, or fatigue.

Meningococcal vaccination is particularly recommended for infants, adolescents, travelers to high-risk areas, and individuals with medical conditions that increase their vulnerability to meningococcal infections. It is an important preventive measure to reduce the risk of severe diseases and associated complications.